Search results
Results From The WOW.Com Content Network
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [ 2][ 32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [ 44][ 45] It is authorized for ...
"The best booster for you is the one that you can get — either the Pfizer or the Moderna can be used, and they can be mixed or matched," said Dr. Robert Kim-Farley, epidemiologist and infectious ...
Pfizer's vaccine reduced the risk of symptomatic infection by 80% in children between 6 months and 4 years of age. Moderna's vaccine had an efficacy of 37% in kids 2 to 5 years old, and 51% in ...
Saturday 16 September 2023 21:00 , Maggie O’Neill. The cost of the new Covid vaccines may prohibit some people from getting them, experts are warning. Pfizer and BioNTech set their price at $120 ...
Former corporate logos (until 2021). The headquarters of Pfizer in Tokyo, Japan. Pfizer Inc. ( / ˈfaɪzər / FY-zər) [ 3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer ...
Pfizer–BioNTech's BNT162b2 mRNA vaccine has to be kept between −80 and −60 °C (−112 and −76 °F). [ 91 ] [ 92 ] Moderna says their mRNA-1273 vaccine can be stored between −25 and −15 °C (−13 and 5 °F), [ 93 ] which is comparable to a home freezer, [ 92 ] and that it remains stable between 2 and 8 °C (36 and 46 °F) for up to ...
“Consequently, the Pfizer-BioNTech Covid vaccine is authorized for use as a booster dose among certain individuals who completed a primary series of the Pfizer-BioNTech Covid vaccine,” Dr ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [ 7] and mass vaccinations began four days later. The Moderna ...